Description
Cagri/Reta 10/10mg is a dual synthetic peptide formulation combining Cagrilintide and Retatrutide, studied in preclinical and clinical research for its interactions with amylin receptor, GLP-1 receptor, GIP receptor, and glucagon receptor binding and associated metabolic signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
This dual-peptide combination has been investigated in peer-reviewed studies examining amylin and incretin receptor co-activation and associated energy homeostasis signaling mechanisms. References are provided for informational purposes relating to published scientific literature.
Product Specifications
- Composition: Cagrilintide 10mg + Retatrutide 10mg (20mg total)
- Purity: 99%+ verified by LCMS
- Format: Lyophilized powder
- Storage: -20°C, protected from light
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.











